Mark Rylance Reprises Award-Winning Performance in Jerusalem at West End's Apollo | Playbill

News Mark Rylance Reprises Award-Winning Performance in Jerusalem at West End's Apollo
Mark Rylance returns to the West End in his Olivier and Tony-winning performance as Johnny "Rooster" Byron in Jerusalem, resuming performances at the Apollo Theatre—where the play originally ran after transferring from the Royal Court in 2010—Oct. 8, prior to an official opening Oct. 17.

Mark Rylance
Mark Rylance Photo by Simon Annand

It will play a 14-week engagement through Jan. 14, 2012. Rylance is joined by Mackenzie Crook (Ginger), Max Baker (Wesley), Alan David (The Professor), Aimeé-Ffion Edwards (Phaedra), Johnny Flynn (Lee), Geraldine Hughes (Dawn), Danny Kirrane (Davey), Sophie McShera (Pea), Charlotte Mills (Tanya), Sarah Moyle (Ms. Fawcett), Harvey Robinson (Mr. Parsons), Barry Sloane (Troy Whitworth) and Lennie Harvey, Dylan Standen and Archie Waite (Marky 1,2,3).

According to press notes, Jerusalem is a "comic, contemporary vision of life in our green and pleasant land. On St. George's Day, the morning of the local county fair, Johnny Byron is a wanted man. The Council officials want to serve him an eviction notice, his son wants his dad to take him to the fair and Troy Whitworth wants to give him a serious kicking."

Designs are by Ultz, with lighting by Mimi Jordan Sherin, sound by Ian Dickinson for Autograph and music by Stephen Warbeck. Jerusalem is produced in the West End by Royal Court Theatre Productions and by Sonia Friedman Productions.

Butterworth’s award-winning play returns to the West End following record-breaking, sold-out runs at the Royal Court and the Apollo Theatres in 2009 and 2010, respectively. It also played Broadway's Music Box Theatre.

For tickets call  0844 412 4658 or 020 7565 5000 or visit

Click Here to Shop for Theatre
Merchandise in the Playbill Store
Today’s Most Popular News:

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting with your ad blocker.
Thank you!